Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
16,463,909
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
26,596,757
-
Shares change
-
+5,536,862
-
Total reported value, excl. options
-
$845,609,249
-
Value change
-
+$179,542,242
-
Put/Call ratio
-
95.71%
-
Number of buys
-
73
-
Number of sells
-
-31
-
Price
-
$31.79
Significant Holders of RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT) as of Q2 2021
136 filings reported holding RAPT - RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2021.
RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26,596,757 shares
.
Largest 10 shareholders include Column Group LLC (3,885,679 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,593,399 shares), PERCEPTIVE ADVISORS LLC (2,475,660 shares), BlackRock Inc. (1,608,662 shares), Ponoi Management, LLC (1,599,417 shares), WELLINGTON MANAGEMENT GROUP LLP (1,321,135 shares), KPCB XV Associates, LLC (1,297,063 shares), VANGUARD GROUP INC (913,916 shares), Alphabet Inc. (788,813 shares), and REGENTS OF THE UNIVERSITY OF CALIFORNIA (782,593 shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.